Up next
Author
Tags
Share article
The post has been shared by 0 people.
Facebook 0
Twitter 0
Pinterest 0
Mail 0
Eli Lilly seeks FDA approval for weight loss drug tirzepatide – CBS News


Watch CBS News



Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


Source link

You May Also Like

California deputy allegedly sexually abused teenager over 5-year period: authorities

A Stanislaus County, California, deputy was arrested Tuesday morning on allegations that…

Mom living in hotel while daughter battles kidney failure gets new home

A Georgia mother who was living out of a hotel while one…

Relocated ‘nuisance’ bear travels 1,000 miles across 4 states to return to park

A black bear that was relocated by a national park after becoming…

Marvel Star Reportedly Set To Play Young Trump In New Film

A face that will be embarrassingly familiar to Rudy Giuliani will also…